Conception rates after medical versus surgical evacuation of early miscarriage

2021 ◽  
Vol 115 (1) ◽  
pp. 118-124 ◽  
Author(s):  
Yossi Tzur ◽  
Ofri Samueloff ◽  
Yael Raz ◽  
Shikma Bar-On ◽  
Ido Laskov ◽  
...  
Author(s):  
Alexander Younsi ◽  
Lennart Riemann ◽  
Cleo Habel ◽  
Jessica Fischer ◽  
Christopher Beynon ◽  
...  

AbstractIn an aging Western society, the incidence of chronic subdural hematomas (cSDH) is continuously increasing. In this study, we reviewed our clinical management of cSDH patients and identified predictive factors for the need of reoperation due to residual or recurrent hematomas with a focus on the use of antithrombotic drugs. In total, 623 patients who were treated for cSDH with surgical evacuation between 2006 and 2016 at our department were retrospectively analyzed. Clinical and radiological characteristics and laboratory parameters were investigated as possible predictors of reoperation with univariate and multivariate analyses. Additionally, clinical outcome measures were compared between patients on anticoagulants, on antiplatelets, and without antithrombotic medication. In univariate analyses, patients on anticoagulants and antiplatelets presented significantly more often with comorbidities, were significantly older, and their risk for perioperative complications was significantly increased. Nevertheless, their clinical outcome was comparable to that of patients without antithrombotics. In multivariate analysis, only the presence of comorbidities, but not antithrombotics, was an independent predictor for the need for reoperations. Patients on antithrombotics do not seem to necessarily have a significantly increased risk for residual hematomas or rebleeding requiring reoperation after cSDH evacuation. More precisely, the presence of predisposing comorbidities might be a key independent risk factor for reoperation. Importantly, the clinical outcomes after surgical evacuation of cSDH are comparable between patients on anticoagulants, antiplatelets, and without antithrombotics.


Author(s):  
Buqing Liang ◽  
Yilu Zhang ◽  
Anthony V. Nguyen ◽  
Jason H. Huang ◽  
Dongxia Feng

Author(s):  
D Guha ◽  
S Coyne ◽  
RL Macdonald

Background: Antithrombosis (AT), with antiplatelets or anticoagulants, is a significant risk factor for the development of chronic subdural hematomas (cSDH). Resumption of AT following hematoma evacuation is variable, with scant evidence for guidance. Methods: We retrospectively analyzed 479 patients with surgically-evacuated cSDH at St. Michael’s Hospital from 2007-2012. Collected variables included type of AT, indication for AT, timing and type of postoperative complications, and restart intervals for AT agents. Postoperative complications were classified as major or minor hemorrhages, or thromboembolism. Results: Among all patients, 14.8% experienced major hemorrhage, 23.0% minor hemorrhage, and 1.67% thromboembolism. Patients on any preoperative AT were at higher risk of major hemorrhage (OR=1.93, p=0.014), experienced earlier major hemorrhage (mean 16.2 versus 26.5d, p=0.052) and earlier thromboembolism (mean 2.7 versus 51.5d, p=0.036). The type of agent did not affect complication frequency or timing. Patients restarted on any AT postoperatively were at decreased risk of major rebleed following resumption, than those not restarted (OR=0.06, p<0.01). Conclusions: Patients on preoperative AT experienced thromboembolism significantly earlier, at 3d postoperatively, with no increase in rebleed risk following AT resumption. We provide cursory evidence that resuming AT early, at 3d postoperatively, may be safe. Larger prospective studies are required for definitive recommendations.


1993 ◽  
Vol 66 (4) ◽  
pp. 363-372 ◽  
Author(s):  
R. J. Ptettyman ◽  
C. J. Cordle ◽  
G. D. Cook

1991 ◽  
Vol 53 (1) ◽  
pp. 89-96 ◽  
Author(s):  
R. C. F. Findlater ◽  
W. Haresign ◽  
R. M. Curnock ◽  
N. F. G. Beck

ABSTRACTThe field application of a laparoscopic technique to permit intra-uterine insemination of ewes with frozen-thawed semen was examined in two trials, conducted over successive years, to (i) determine the optimum time of insemination relative to sponge removal/pregnant mares's serum gonadotropin (PMSG) injection and (ii) establish the relationship between semen dose and conception rate. Pooled semen was used in both trials, and each involved > 900 ewes in a number of commercial flocks.Maximum conception rates were achieved when insemination was conducted between 54 h and 60 h after sponge removal/ PMSG injection. However, there was no significant difference in conception rate when motile sperm numbers were reduced from 52·2 × 106to 13·0 × 106 motile sperm per uterine horn.The overall conception rates (pooled over flocks and treatment groups) were 56% and 58% for the two trials, with a wide degree of variation between flocks in both cases (45% to 79% for trial 1 and 45% to 69% for trial 2). However, there was evidence for consistent differences in conception rates between the six flocks involved in both years of the trials.


Sign in / Sign up

Export Citation Format

Share Document